Found 3 articles for: "Stevens-Johnson syndrome"
Generalized Bullous Fixed-Drug Eruption in a 15-Year-Old Child With Becker Muscular Dystrophy and Epilepsy
June 2026 | Volume 25 | Issue 6 | Case Reports | 565 | Copyright © June 2026
Introduction: Generalized bullous fixed drug eruption (GBFDE) is a potentially life-threatening condition, typically triggered by a range of medications. Its incidence in the ped...
Read MoreManagement of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Case Report and Literature Review
November 2023 | Volume 22 | Issue 11 | Case Reports | e24 | Copyright © November 2023
Introduction: Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) is a rare and dangerous dermatologic emergency. It can have different presentations, especially in pat...
Read MoreCase Series of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis With Nivolumab and Nivolumab/ Ipilimumab Combination Therapy in Metastatic Melanoma
May 2022 | Volume 21 | Issue 5 | Case Reports | 529 | Copyright © May 2022
Nivolumab (anti PD-1 antibody) and ipilimumab (anti CTLA-4 antibody) are immune checkpoint inhibitors (ICI) that effectively stimulate the native T cell response and lead to an antitumor response. The...
Read More
© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.